Valuation : Medicure Inc.

Market Cap 26.09M 18.78M 16.18M 15.17M 13.85M 1.79B 26.17M 180M 70.23M 906M 70.5M 68.97M 3B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 23.15M 16.66M 14.36M 13.46M 12.29M 1.59B 23.22M 160M 62.31M 804M 62.55M 61.19M 2.67B EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day+31.58%
1 week+95.31%
Current month+92.31%
1 month+140.38%
3 months+125.23%
6 months+103.25%
Current year+119.30%
1 week 1.28
Extreme 1.28
2.5
1 month 1.25
Extreme 1.25
2.5
Current year 0.85
Extreme 0.85
2.5
1 year 0.85
Extreme 0.85
2.5
3 years 0.63
Extreme 0.63
2.5
5 years 0.63
Extreme 0.63
2.5
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 15/09/1997
Director of Finance/CFO 48 15/07/2011
Chief Tech/Sci/R&D Officer - 01/07/2019
Director TitleAgeSince
Chairman 79 15/09/1997
Director/Board Member 93 28/02/2000
Director/Board Member 56 22/01/2013
Date Insider Type Main position Quantity % Market Cap.
30/7/26 Option

Chief Technology Officer

-20,000 0.1916%
28/3/25 Option

Chief Technology Officer

7,500 0.0719%
28/3/25 Option

Director

7,200 0.0690%
Change 5-day change 1-year change 3-year change Capi.($)
+31.58%+95.31%+117.39%+92.31% 18.78M
-1.59%-3.35%+52.37%+93.70% 69.54B
-1.34%-0.75%+48.21%+91.86% 64.97B
+0.30%-0.69%+52.56%+10.23% 26.51B
-2.35%-5.75%-12.90%+448.54% 25.89B
-8.37%-12.43%+2.08%-16.71% 25.64B
-0.96%+10.36%+283.06%+436.50% 20.22B
-0.51%+0.23%+35.77%-18.70% 19.98B
-1.91%-4.37%+13.28%+535.19% 15.69B
-1.47%+0.68%+45.51%+143.08% 13.49B
Average +1.34%+7.80%+63.73%+181.60% 28.19B
Weighted average by Cap. -1.93%-1.50%+53.73%+151.51%

Financials

2024 2025
Net sales 21.91M 15.77M 13.59M 12.74M 11.63M 1.51B 21.98M 151M 58.97M 761M 59.2M 57.91M 2.52B 28.86M 20.77M 17.9M 16.78M 15.32M 1.98B 28.95M 199M 77.67M 1B 77.97M 76.28M 3.32B
Net income -1.04M -748K -644K -604K -552K -71.47M -1.04M -7.17M -2.8M -36.08M -2.81M -2.75M -120M -7.1M -5.11M -4.4M -4.13M -3.77M -488M -7.12M -48.96M -19.1M -246M -19.18M -18.76M -817M
Net Debt -6.32M -4.55M -3.92M -3.67M -3.35M -435M -6.34M -43.58M -17M -219M -17.07M -16.7M -727M -2.94M -2.12M -1.83M -1.71M -1.56M -203M -2.95M -20.31M -7.92M -102M -7.96M -7.78M -339M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume
28/08/26 CAD 2.500 +31.58% 13,884
27/08/26 CAD 1.900 +29.25% 42,696
26/08/26 CAD 1.470 +13.08% 8,512
25/08/26 CAD 1.300 +1.56% 2,600
21/08/26 CAD 1.280 -1.54% 6,032